This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
March 23–25, 2026
FIL (Feira Internacional de Lisboa), Lisbon, PortugalMarch 31 – April 1, 2026 | Digital Partnering

Roel Bulthuis
Managing Partner at Syncona
Speaker

Profile

Roel Bulthuis is a Managing Partner and the Head of Investments of Syncona Investment Management Ltd. He manages the investment team and utilises more than 20 years of life science venture capital, business development, and investment banking experience to help Syncona deliver value through the investment cycle. He is a Board member of iOnctura and Anaveon.

Roel joined Syncona from Inkef Capital, an Amsterdam-based venture capital firm focused on life science investments. As Managing Partner and head of healthcare, he led the firm’s growth into a leading European healthcare VC platform. Before this he served as SVP and Managing Director of Merck Group’s M-Ventures for almost 10 years, where he played an instrumental role in creating the business and building it into a leading corporate venture capital fund. Prior to his time at M-Ventures, Roel held senior positions in global business development at Merck Serono and was in the investment banking team at Fortis Bank. Roel holds a MSc in Biopharmaceutical Sciences from Leiden University, Netherlands, and an MBA in Finance from the Helsinki School of Economics, Finland. Roel is a Kauffman fellow and a Level20 mentor and is highly driven by the development of next generation investor and entrepreneurial talent.

Agenda Sessions

  • Forecasting the waves: Biopharma investment landscape

    13:00